| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.8 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | -0.0091 | 0.8 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | -0.0091 | 0.8 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | -0.019 | 0.8 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | STF-62247 | GDSC1000 | pan-cancer | AAC | -0.0082 | 0.8 |